share_log

Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director NEWHALL CHARLES W III

SEC ·  Nov 12, 2024 13:21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more